D&B Business Directory
Novartis AG
Overview
Novartis is a multinational group of companies specializing in the research, development, manufacturing and marketing of a broad range of innovative pharmaceuticals medicines. In late 2023, the company reorganized its operations into five organizational units. These are Biomedical Research, Development, Operations, and two commercial units: US and International. Global functions support these organizational units in the execution of their work. We ...
Read More
are engaged in the research, development, manufacturing, distribution, and commercialization and sale of innovative medicines, with a focus on the core therapeutic areas: cardiovascular, renal and metabolic; immunology; neuroscience; and oncology; as well as established brands. Novartis sells its products in about 130 countries and generates most of its revenue from international customers. In 2023, Novartis completed its transformation into a pure-play innovative medicines business, with the successful spin-off of Sandoz.
Read Less
Vasant Kalathur Narasimhan   See more contacts
Management of Companies and Enterprises Holding companies, nec
?
?
Actual
$57.13 billion
Actual
10.85% -19.59% $102,246 DEC
? ?
Swiss:NOVN
Contacts
Get in Touch with 28 Principals*
  • Vasant Kalathur Narasimhan
    Managing Director and Chairperson
  • Contact 2
    ?
  • Contact 3
    ?
  • Contact 4
    ?
D&B Hoovers Logo

Dynamic search and list-building capabilities

Real-time trigger alerts

Comprehensive company profiles

Valuable research and technology reports

Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$57.13 billion USD
Actual
Stay on top of your Business Credit File
Get full access to view your D&B business credit file now for just $39/month!
View D&B Scores & Ratings